Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the good and bad effects of atezolizumab given in
combination with a personalized cancer vaccine in patients with urothelial cancer either
after surgery to remove organ where the tumor arose (for example, removal of the bladder) or
for urothelial cancer that has spread to other organs.